All News

Cancer-related fatigue guidelines from 2024 explained which interventions help manage the side effect and explain why certain medications may not be helpful.

Not only Julie Kirby, RN, OCN, make a recovery, but she has returned to nursing and manages our chemotherapy department.

My wife and children were by my side as I underwent grueling and life-changing prostate cancer treatment.

Cancer gave me a new “fluffy” perspective on life.

From Susan Wojcicki and Rachael Lillis dying of cancer to the President Biden announcing that Cancer Moonshot initiative received $150 million, here’s what’s happening in the oncology space.

Patients with NSCLC who are overweight or obese should discuss chemotherapy versus immunotherapy for frontline treatment, research showed.

Imfinzi has been approved as a presurgical treatment with platinum-based chemotherapy and postsurgical treatment alone in surgically removable NSCLC.

Researchers have identified genetic differences that can make leukemia relapse more or less likely among pediatric patients.

Treatment with postoperative radiotherapy for early breast cancer was beneficial within the first decade, but then the risk of recurrence may increase.

Patients with NSCLC taking five or more medications tended to have worse survival, highlighting the need for medication management, research showed.

The Food and Drug Administration will fast-track the development of AC699 for patients with ER-positive, HER2-negative ESR1-mutant advanced or metastatic breast cancer.

Researchers compared health-related quality of life among patients ages 60 and older with acute myeloid leukemia undergoing different chemotherapy regimens.

Niktimvo was approved for adults and children with chronic, pretreated graft-versus-host disease.

Reflecting on different reminders that have helped me maintain an empowering mindset and stay motivated on healing with cancer, one day at a time.

Patients with locally advanced muscle-invasive bladder cancer may benefit from dose-dense gemcitabine and cisplatin.

My local Gilda’s Club chapter helped me through cancer, so I continued to go after finishing treatment

Olomorasib plus Keytruda was proven to be safe and well tolerated for patients with KRAS G12C-mutant non-small cell lung cancer.

After a decade of surviving cancer, I’ve wondered if it’s possible to truly forget I had breast cancer. After a small incident, I thought perhaps it was possible. Now I’m not so sure.

Levels of tumor-infiltrating lymphocytes in patients with stage 1 triple-negative breast cancer may be a biomarker to help with optimized treatment plans.

Helping others through their cancer experience helped with my own feelings of survivor's guilt.

With attitudes evolving around telemedicine in oncology, one doctor explains how patients can get ready for a video appointment with their provider.

After my myeloma diagnosis, each day is my own personal Olympics, filled with trials and triumph.

One researcher explains the science behind Lymphir, recently approved by the FDA for relapsed/refractory cutaneous T-cell lymphoma.

When I noticed a lump in my breast, I immediately knew what it would be, so I worked to advocate for myself.

Even though my wife became quadriplegic after her breast cancer progressed, our insurance still did not help us out, so I became her caregiver full-time.

Walking up and down the street a few times a day can help prevent patients with kidney or bladder cancers from becoming deconditioned.

During chemotherapy for my chronic lymphocytic leukemia, I try my best to appreciate the positive aspects of life, like flowers and friends.

One expert explains how a break in TKI treatment could alleviate some toxicities, such as rash, for patients with non-small cell lung cancer.